The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition

Abstract

BAckgRound: The renin-angiotensin aldosterone system (RAAS) is a hormonal cascade that functions in the homeostatic control of arterial pressure, tissue perfusion, and extracellular volume. dysregulation of the RAAS plays an important role in the pathogenesis of cardiovascular and renal disorders.oBjecTIveS: To review the role of the RAAS in the development of hypertensive cardiovascular disease and related conditions and provide an overview of the classes of pharmacologic agents that inhibit this system. ReSulTS: The RAAS is initiated by the regulated secretion of renin, the rate-limiting enzyme that catalyzes the hydrolysis of angiotensin (Ang) I from the n-terminus of angiotensinogen. Ang I is in turn hydrolyzed by angiotensin-converting enzyme (Ace) to form Ang II, a potent vasoconstrictor and the primary active product of the RAAS. Recent evidence has suggested that other metabolites of Ang I and II may have biological activity, particularly in tissues. development of agents that block the RAAS (e.g., beta blockers, Ace inhibitors [AceIs], and angiotensin receptor blockers [ARBs]) began as a therapeutic strategy to treat hypertension. Preclinical and clinical studies have indicated important additional cardiovascular and renal therapeutic benefits of AceIs and ARBs. However, blockade of the RAAS with these agents is incomplete.concluSIon: Therapeutic approaches that target more complete inhibition of the RAAS may offer additional clinical benefits for patients with cardiovascular and renal disorders. These approaches may include dual blockade using AceIs and ARBs in combination, or new therapeutic modalities such as direct renin inhibition with aliskiren, recently approved for the treatment of hypertension. Medicine, new York, and chief, Cardiology/ Hypertension/endocrinology Practice, and director, Hypertension Research laboratory, James J. Peters vA Medical Center, Bronx, nY. AutHoR CoRReSPonDenCe: Steven A. Atlas, MD, 130 W. Kingsbridge Rd., Bronx, nY 10468. tel: (718) Fax: (718) 741-4295; e-mail: steven.atlas@med.va.gov regulator of sodium and potassium balance. 4 These landmark discoveries established the concept that a single system, the RAAS, was involved in the regulation of both blood pressure and fluid and electrolyte balance. Steven A. AtlAS, MD, is an associate professor of medicine, Mount Sinai School of

Prenatal exposure to lipopolysaccharide alters the intrarenal renin–angiotensin system and renal damage in offspring rats

“…Ang I is in turn hydrolyzed by ACE to form Ang II, a potent vasoconstrictor and the primary active product of RAS. 24 Ang II has an important role in the pathogenesis of cardiovascular and renal disorders. In addition, an intact RAS is essential for normal kidney development.…”

Renal Angiotensin-Converting Enzyme Is Essential for the Hypertension Induced by Nitric Oxide Synthesis Inhibition

“…However, any interpretation considering endothelial ACE as an important locus for hypertension faces two fundamental challenges: First, many hypertensive patients have normal or low renin levels, which undermine the capacity of endothelial ACE to generate angiotensin II. 2,3 Second, ACE inhibitors continue to reduce BP even after plasma angiotensin II levels have returned to normal, a phenomenon known as angiotensin II escape. 4,5 In addition to the endothelium, large amounts of ACE are found in renal tissues.…”

Polypharmacy Treatment of Hypertensionin Public Health Centers

“…By reducing circulating angiotensin II levels, ACE inhibitors also decrease the secretion of aldosterone, resulting in decreased sodium and water retention. 6 The most commonly used of two drugcombination were the ACE inhibitors with CCBs. In patients with both diabetes and hypertension, ACE inhibitors provide clinical benefits that appear to be independent of blood pressure reduction.…”